2118 WALSH AVE., SUITE 210, SANTA CLARA, CA
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
Compensatory Arrangements Approved for President Branislav Vajdic
Announces Closing of $10 Million Public Offering of Common Stock
Other Events
News, Material Contracts
Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
Changing the Company's Accountant
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Statement of Changes in Beneficial Ownership
Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Delisting Amendment
Submission Upload
Correspondence
Prospectus Filed Pursuant to Rule 424(b)(1)